Stiborová M - Search Results

1

The epidemiology, diagnosis, and management of aristolochic acid nephropathy: a narrative review.

Gökmen MR, Cosyns JP, Arlt VM, Stiborová M, Phillips DH, Schmeiser HH, Simmonds MS, Cook HT, Vanherweghem JL, Nortier JL, Lord GM. Gökmen MR, et al. Among authors: stiborova m. Ann Intern Med. 2013 Mar 19;158(6):469-77. doi: 10.7326/0003-4819-158-6-201303190-00006. Ann Intern Med. 2013. PMID: 23552405 Review.

2

The effect of aristolochic acid I on expression of NAD(P)H:quinone oxidoreductase in mice and rats--a comparative study.

Bárta F, Levová K, Frei E, Schmeiser HH, Arlt VM, Stiborová M. Bárta F, et al. Among authors: stiborova m. Mutat Res Genet Toxicol Environ Mutagen. 2014 Jul 1;768:1-7. doi: 10.1016/j.mrgentox.2014.01.012. Epub 2014 Apr 24. Mutat Res Genet Toxicol Environ Mutagen. 2014. PMID: 24769487 Free article.

3

Balkan endemic nephropathy: an update on its aetiology.

Stiborová M, Arlt VM, Schmeiser HH. Stiborová M, et al. Arch Toxicol. 2016 Nov;90(11):2595-2615. doi: 10.1007/s00204-016-1819-3. Epub 2016 Aug 19. Arch Toxicol. 2016. PMID: 27538407 Free PMC article. Review.

4

DNA Adducts Formed by Aristolochic Acid Are Unique Biomarkers of Exposure and Explain the Initiation Phase of Upper Urothelial Cancer.

Stiborová M, Arlt VM, Schmeiser HH. Stiborová M, et al. Int J Mol Sci. 2017 Oct 14;18(10):2144. doi: 10.3390/ijms18102144. Int J Mol Sci. 2017. PMID: 29036902 Free PMC article. Review.

5

Balkan Endemic Nephropathy and the Causative Role of Aristolochic Acid.

Jelaković B, Dika Ž, Arlt VM, Stiborova M, Pavlović NM, Nikolić J, Colet JM, Vanherweghem JL, Nortier JL. Jelaković B, et al. Among authors: stiborova m. Semin Nephrol. 2019 May;39(3):284-296. doi: 10.1016/j.semnephrol.2019.02.007. Semin Nephrol. 2019. PMID: 31054628 Review.

6

Aristolochic acid mutagenesis: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer.

Arlt VM, Stiborová M, vom Brocke J, Simões ML, Lord GM, Nortier JL, Hollstein M, Phillips DH, Schmeiser HH. Arlt VM, et al. Among authors: stiborova m. Carcinogenesis. 2007 Nov;28(11):2253-61. doi: 10.1093/carcin/bgm082. Epub 2007 Apr 13. Carcinogenesis. 2007. PMID: 17434925 Review.

7

Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy.

Stiborová M, Frei E, Arlt VM, Schmeiser HH. Stiborová M, et al. Mutat Res. 2008 Jan-Feb;658(1-2):55-67. doi: 10.1016/j.mrrev.2007.07.003. Epub 2007 Aug 6. Mutat Res. 2008. PMID: 17851120 Free article. Review.

8

Chemical and molecular basis of the carcinogenicity of Aristolochia plants.

Schmeiser HH, Stiborovà M, Arlt VM. Schmeiser HH, et al. Among authors: stiborova m. Curr Opin Drug Discov Devel. 2009 Jan;12(1):141-8. Curr Opin Drug Discov Devel. 2009. PMID: 19152223 Review.

9

The role of biotransformation enzymes in the development of renal injury and urothelial cancer caused by aristolochic acid: urgent questions and difficult answers.

Stiborova M, Frei E, Arlt VM, Schmeiser HH. Stiborova M, et al. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009 Mar;153(1):5-11. doi: 10.5507/bp.2009.001. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2009. PMID: 19365519 Free article. Review.

10

Role of P450 1A1 and P450 1A2 in bioactivation versus detoxication of the renal carcinogen aristolochic acid I: studies in Cyp1a1-/-, Cyp1a2-/-, and Cyp1a1/1a2-/- mice.

Arlt VM, Levová K, Bárta F, Shi Z, Evans JD, Frei E, Schmeiser HH, Nebert DW, Phillips DH, Stiborová M. Arlt VM, et al. Among authors: stiborova m. Chem Res Toxicol. 2011 Oct 17;24(10):1710-9. doi: 10.1021/tx200259y. Epub 2011 Sep 29. Chem Res Toxicol. 2011. PMID: 21932800

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

289 results

Search Page

Filters